Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024
Open Access
- 8 November 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (12) , ofae666
Abstract
Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy.Keywords
Funding Information
- Centers for Disease Control and Prevention
This publication has 20 references indexed in Scilit:
- Rate of use and effectiveness of oseltamivir in the treatment of influenza illness in high‐risk populations: A systematic review and meta‐analysisHealth Science Reports, 2021
- Clinical Effectiveness of Intravenous Peramivir Compared With Oseltamivir in Patients With Severe Influenza A With Primary Viral Pneumonia: A Randomized Controlled StudyOpen Forum Infectious Diseases, 2020
- Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trialThe Lancet Infectious Diseases, 2020
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)Clinical Infectious Diseases, 2020
- Influenza Antiviral Prescribing Practices and the Influence of Rapid Testing Among Primary Care Providers in the US, 2009–2016Open Forum Infectious Diseases, 2019
- Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal InfluenzaaClinical Infectious Diseases, 2018
- Baloxavir Marboxil for Uncomplicated Influenza in Adults and AdolescentsNew England Journal of Medicine, 2018
- Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled TrialsClinical Infectious Diseases, 2017
- Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trialsThe Lancet, 2015
- Use of Influenza Antiviral Agents by Ambulatory Care Clinicians During the 2012-2013 Influenza SeasonClinical Infectious Diseases, 2014